Animal Pneumoviruses: Molecular Genetics and Pathogenesis
Open accessThe DOI matches its Crossref record; 267 of the 267 references it cites were found in a registry or an index.
Abstract
SUMMARY: Pneumoviruses are single-stranded, negative-sense, nonsegmented RNA viruses of the family Paramyxoviridae, subfamily Pneumovirinae, and include pathogens that infect humans (respiratory syncytial virus and human metapneumovirus), domestic mammals (bovine, ovine, and caprine respiratory syncytial viruses), rodents (pneumonia virus of mice), and birds (avian metapneumovirus). Among the topics considered in this review are recent studies focused on the roles of the individual virus-encoded components in promoting virus replication as well as in altering and evading innate antiviral host defenses. Advances in the molecular technology of pneumoviruses and the emergence of recombinant pneumoviruses that are leading to improved virus-based vaccine formulations are also discussed. Since pneumovirus infection in natural hosts is associated with a profound inflammatory response that persists despite adequate antiviral therapy, we also review the recent experimental treatment strategies that have focused on combined antiviral, anti-inflammatory, and immunomodulatory approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A newly discovered human pneumovirus isolated from young children with respiratory tract disease
van den Hoogen, B. G., de Jong, J. C., Groen, J., Kuiken, T., de Groot, R., Fouchier, R. A. M., & Osterhaus, A. D. M. E. (2001) · Nature Medicine · doi:10.1038/89098 · Cited by 2,186 · cited 4×
“bRSV was first isolated and identified as a unique pathogen in the 1970s, and it is currently the closest known phylogenetic relative of hRSV (360), although there is no evidence for antigenic grouping into A/B strains (104).”
BackgroundInfluentialKIM, H. W., CANCHOLA, J. G., BRANDT, C. D., PYLES, G., CHANOCK, R. M., JENSEN, K., & PARROTT, R. H. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120955 · Cited by 1,981 · cited 1×
“Most important is the possibility that vaccination will result in adverse reactions to naturally occurring hRSV disease, as observed with the formalin-inactivated vaccine used in the 1960s (55, 124, 202, 210).”
BackgroundThe IMpact-RSV Study Group (1998) · Pediatrics · doi:10.1542/peds.102.3.531 · Cited by 1,961
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
Kurt-Jones, E. A., Popova, L., Kwinn, L., Haynes, L. M., Jones, L. P., Tripp, R. A., Walsh, E. E., Freeman, M. W., Golenbock, D. T., Anderson, L. J., et al. (2000) · Nature Immunology · doi:10.1038/80833 · Cited by 1,683
Respiratory Syncytial Virus and Parainfluenza Virus
Hall, C. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442507 · Cited by 1,233 · cited 1×
“The clinical signs and symptoms of acute hRSV infection have been described in significant detail in several recent reviews (86, 141, 155, 161, 162, 216, 372).”
BackgroundIdentification of four conserved motifs among the RNA-dependent polymerase encoding elements.
Poch, O., Sauvaget, I., Delarue, M., & Tordo, N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08565.x · Cited by 1,202 · cited 1×
“(289, 290) described six conserved domains for polymerase proteins of minus-strand RNA viruses, including three functional domains and distinct interdomain regions acting as hinges to assemble the functional domains into an appropriate conformation.”
BackgroundBuchholz, U. J., Finke, S., & Conzelmann, K.-K. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.251-259.1999 · Cited by 1,034 · cited 1×
“(35) described the creation of recombinant”
KAPIKIAN, A. Z., MITCHELL, R. H., CHANOCK, R. M., SHVEDOFF, R. A., & STEWART, C. E. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120954 · Cited by 1,033 · cited 1×
“Most important is the possibility that vaccination will result in adverse reactions to naturally occurring hRSV disease, as observed with the formalin-inactivated vaccine used in the 1960s (55, 124, 202, 210).”
BackgroundGroothuis, J. R., Simoes, E., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292102 · Cited by 744 · cited 1×
“The earliest studies with experimental animals suggested that immunoglobulin preparations containing high-titer antibodies to hRSV (hRSV-Ig) protected against development of severe disease (150, 291, 323).”
BackgroundCHIN, J., MAGOFFIN, R. L., SHEARER, L. A., SCHIEBLE, J. H., & LENNETTE, E. H. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120957 · Cited by 630 · cited 1×
“Most important is the possibility that vaccination will result in adverse reactions to naturally occurring hRSV disease, as observed with the formalin-inactivated vaccine used in the 1960s (55, 124, 202, 210).”
BackgroundField, A. E., Camargo, C. A., Taylor, C. B., Berkey, C. S., Roberts, S. B., & Colditz, G. A. (2001) · Pediatrics · doi:10.1542/peds.107.1.54 · Cited by 614
RESPIRATORY VIRUS IMMUNIZATION
FULGINITI, V. A., ELLER, J. J., SIEBER, O. F., JOYNER, J. W., MINAMITANI, M., & MEIKLEJOHN, G. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120956 · Cited by 607 · cited 1×
“Most important is the possibility that vaccination will result in adverse reactions to naturally occurring hRSV disease, as observed with the formalin-inactivated vaccine used in the 1960s (55, 124, 202, 210).”
BackgroundBoivin, G., Abed, Y., Pelletier, G., Ruel, L., Moisan, D., Côté, S., Peret, T. C. T., Erdman, D. D., & Anderson, L. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/344319 · Cited by 606 · cited 1×
“(360), and evidence of infection has since been collected worldwide (26, 105, 110, 273, 286), with one reported fatality in a stem cell transplant recipient (44).”
BackgroundHuman Metapneumovirus Infections in Young and Elderly Adults
Falsey, A. R., Erdman, D., Anderson, L. J., & Walsh, E. E. (2003) · The Journal of Infectious Diseases · doi:10.1086/367901 · Cited by 595 · cited 1×
“(360), and evidence of infection has since been collected worldwide (26, 105, 110, 273, 286), with one reported fatality in a stem cell transplant recipient (44).”
BackgroundHall, C. B., McBride, J. T., Walsh, E. E., Bell, D. M., Gala, C. L., Hildreth, S., Ten Eyck, L. G., & Hall, W. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082403 · Cited by 550
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA
Calain, P., & Roux, L. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4822-4830.1993 · Cited by 533 · cited 1×
“While the precise sizes of the genomes are strain dependent, the number of nucleotides does not follow the “rule of six” (42, 43, 312), a feature that differentiates the Pneumovirinae from the Paramyxovirinae.”
BackgroundPoch, O., Blumberg, B. M., Bougueleret, L., & Tordo, N. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-5-1153 · Cited by 528 · cited 1×
“(289, 290) described six conserved domains for polymerase proteins of minus-strand RNA viruses, including three functional domains and distinct interdomain regions acting as hinges to assemble the functional domains into an appropriate conformation.”
BackgroundHull, J. (2000) · Thorax · doi:10.1136/thorax.55.12.1023 · Cited by 515 · cited 1×
“kowski and colleagues (177, 178) have provided evidence supporting a relationship between disease and a susceptibility lo-”
BackgroundGraham, B. S., Bunton, L. A., Wright, P. F., & Karzon, D. T. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115362 · Cited by 502 · cited 2×
“All describe the moderate influx of inflammatory cells, with reports including lymphocytes and eosinophils as components of the respiratory infiltrates (120, 145, 147, 319, 320).”
BackgroundInvolvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus
Haynes, L. M., Moore, D. D., Kurt-Jones, E. A., Finberg, R. W., Anderson, L. J., & Tripp, R. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10730-10737.2001 · Cited by 496 · cited 1×
“in innate host defense against hRSV in vivo (158, 170, 222).”
BackgroundAnalysis of the Genomic Sequence of a Human Metapneumovirus
van den Hoogen, B. G., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2002) · Virology · doi:10.1006/viro.2001.1355 · Cited by 479 · cited 5×
“amount of virus gene sequence that is available (18, 245, 360, 361).”
BackgroundInfluentialCX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
Tripp, R. A., Jones, L. P., Haynes, L. M., Zheng, H., Murphy, P. M., & Anderson, L. J. (2001) · Nature Immunology · doi:10.1038/90675 · Cited by 456
The PREVENT Study Group (1997) · Pediatrics · doi:10.1542/peds.99.1.93 · Cited by 450
Collins, P. L., Hill, M. G., Camargo, E., Grosfeld, H., Chanock, R. M., & Murphy, B. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11563 · Cited by 450 · cited 4×
“rough endoplasmic reticulum (ER), forming a structure that is presumed to represent a single virion spike (62).”
BackgroundInfluentialChildren with Respiratory Disease Associated with Metapneumovirus in Hong Kong
Peiris, J. S. M., Tang, W.-H., Chan, K.-H., Khong, P.-L., Guan, Y., Lau, Y.-L., & Chiu, S. S. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0906.030009 · Cited by 424
Karron, R. A., Buonagurio, D. A., Georgiu, A. F., Whitehead, S. S., Adamus, J. E., Clements-Mann, M. L., Harris, D. O., Randolph, V. B., Udem, S. A., Murphy, B. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13961 · Cited by 420 · cited 1×
“(205) have characterized a mutant hRSV strain, cp-52,”
BackgroundPrimary respiratory syncytial virus infection in mice
Graham, B. S., Perkins, M. D., Wright, P. F., & Karzon, D. T. (1988) · Journal of Medical Virology · doi:10.1002/jmv.1890260207 · Cited by 393
Characterization of human metapneumoviruses isolated from patients in North America
Peret, T. C. T., Boivin, G., Li, Y., Couillard, M., Humphrey, C., Osterhaus, A. D. M. E., Erdman, D. D., & Anderson, L. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/340518 · Cited by 392
Demonstration that Glycoprotein G Is the Attachment Protein of Respiratory Syncytial Virus
Levine, S., Klaiber-Franco, R., & Paradiso, P. R. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-9-2521 · Cited by 367 · cited 1×
“The conventional model for pneumovirus attachment involves the virus G protein interacting with a molecule or molecules on the target cell surface (232).”
BackgroundEverard, M. L., Swarbrick, A., Wrightham, M., McIntyre, J., Dunkley, C., James, P. D., Sewell, H. F., & Milner, A. D. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.71.5.428 · Cited by 365 · cited 1×
“While lymphocytes were predominant in postmortem specimens, more recent studies have pointed to neutrophil influx as an earlier acute cellular response and to neutrophil-mediated activities as a major cause of respiratory symptoms (107, 209, 328, 370).”
BackgroundKamps, M. P., Taylor, S. S., & Sefton, B. M. (1984) · Nature · doi:10.1038/310589a0 · Cited by 338 · cited 1×
“Domain III contains the polymerase GDNQ motif, and domain IV contains a putative ATP binding site (200).”
BackgroundLambert, D. M., Barney, S., Lambert, A. L., Guthrie, K., Medinas, R., Davis, D. E., Bucy, T., Erickson, J., Merutka, G., & Petteway, S. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2186 · Cited by 336
Techaarpornkul, S., Barretto, N., & Peeples, M. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6825-6834.2001 · Cited by 336 · cited 2×
“(341) demonstrating that recombinant RSV with deleted G and SH proteins not only was able to infect epithelial cells in”
BackgroundNosocomial Respiratory Syncytial Virus Infections
Hall, C. B., Douglas, R. G., Geiman, J. M., & Messner, M. K. (1975) · New England Journal of Medicine · doi:10.1056/nejm197512252932604 · Cited by 322
Cell surface heparan sulfate and its roles in assisting viral infections
Liu, J., & Thorp, S. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1026 · Cited by 311
Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection
Hallak, L. K., Spillmann, D., Collins, P. L., & Peeples, M. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10508-10513.2000 · Cited by 311 · cited 2×
“(163, 164) reported that only N-sulfated moieties of GAGs (and not C6-O or C2-O sulfation) are important mediators of RSV infection and later documented the specific role of iduronic acid-substi-”
BackgroundWertz, G. W., Collins, P. L., Huang, Y., Gruber, C., Levine, S., & Ball, L. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4075 · Cited by 304 · cited 2×
“A final interesting feature of the G genes of hRSV and PVM is the presence of a small open reading frame just 5 to the main coding region, of function unknown (295, 373).”
BackgroundSmith, D. W., Frankel, L. R., Mathers, L. H., Tang, A. T. S., Ariagno, R. L., & Prober, C. G. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250105 · Cited by 301
Dexamethasone and Salbutamol in the Treatment of Acute Wheezing in Infants
Tal, A., Bavilski, C., Yohai, D., Bearman, J. E., Gorodischer, R., & Moses, S. W. (1983) · Pediatrics · doi:10.1542/peds.71.1.13 · Cited by 297 · cited 1×
“Unfortunately, these trials suggest that when used alone in the absence of antivirals, glucocorticoid treatment has only marginal, if any, benefit in the treatment of hRSV-infection and its associated inflammatory response (72, 83, 84, 212, 213, 231, 307, 331, 334, 338, 365).”
BackgroundMetapneumovirus and acute wheezing in children
Jartti, T., van den Hoogen, B., Garofalo, R. P., Osterhaus, A. D., & Ruuskanen, O. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11391-2 · Cited by 297 · cited 2×
“trations of interleukin-8 (IL-8) in nasal secretions from patients infected with hMPV (187).”
BackgroundCollins, P. L., Hill, M. G., Cristina, J., & Grosfeld, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.81 · Cited by 296 · cited 3×
“, proteins that must be added for efficient first-round virus replication) are the N, P, and L proteins, the presence of the M2 gene significantly enhanced the production of full length virus mRNA (62, 63, 112, 152, 388).”
BackgroundDomachowske, J. B., Dyer, K. D., Bonville, C. A., & Rosenberg, H. F. (1998) · The Journal of Infectious Diseases · doi:10.1086/515322 · Cited by 293 · cited 7×
“(ii) New antiviral strategies: fusion inhibitors, RNases, and others.”
BackgroundInfluentialSelf-citationGarofalo, R., Kimpen, J. L. L., Welliver, R. C., & Ogra, P. L. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80592-x · Cited by 285 · cited 1×
“Eosinophils are also recruited to the lungs in response to primary hRSV bronchiolitis (133, 169), and both neutrophils and eosinophils are recruited to lung tissue in the PVM model of acute pneumovirus infection in vivo (88).”
BackgroundBermingham, A., & Collins, P. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11259 · Cited by 278 · cited 1×
“However, there are some conflicting data suggesting that high levels of N protein may also stimulate transcription, and, more recently, a role for M2-2 protein has been proposed (21).”
BackgroundTaber, L. H., Knight, V., Gilbert, B. E., McClung, H. W., Wilson, S. Z., Norton, H. J., Thurson, J. M., Gordon, W. H., Atmar, R. L., & Schlaudt, W. R. (1983) · Pediatrics · doi:10.1542/peds.72.5.613 · Cited by 271
Feldman, S. A., Audet, S., & Beeler, J. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6442-6447.2000 · Cited by 270 · cited 1×
“While the precise nature of the cellular receptor has not been identified, current evidence suggests that one or more cellular glycosaminoglycans or heparin-like molecules are involved (116, 163, 164, 218, 342).”
BackgroundRespiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment
Domachowske, J. B., & Rosenberg, H. F. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.298 · Cited by 260 · cited 1×
“The clinical signs and symptoms of acute hRSV infection have been described in significant detail in several recent reviews (86, 141, 155, 161, 162, 216, 372).”
BackgroundSelf-citationCulley, F. J., Pollott, J., & Openshaw, P. J. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020943 · Cited by 259 · cited 1×
“clearance have been inferred from rodent studies (81, 146, 147).”
BackgroundEsper, F., Boucher, D., Weibel, C., Martinello, R. A., & Kahn, J. S. (2003) · Pediatrics · doi:10.1542/peds.111.6.1407 · Cited by 259 · cited 1×
“(360), and evidence of infection has since been collected worldwide (26, 105, 110, 273, 286), with one reported fatality in a stem cell transplant recipient (44).”
BackgroundFearns, R., & Collins, P. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5852-5864.1999 · Cited by 256 · cited 2×
“, proteins that must be added for efficient first-round virus replication) are the N, P, and L proteins, the presence of the M2 gene significantly enhanced the production of full length virus mRNA (62, 63, 112, 152, 388).”
BackgroundFeldman, S. A., Hendry, R. M., & Beeler, J. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6610-6617.1999 · Cited by 256
Collins, P. L., Huang, Y. T., & Wertz, G. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7683 · Cited by 252
Heegaard, P. M. H., Godson, D. L., Toussaint, M. J. M., Tjørnehøj, K., Larsen, L. E., Viuff, B., & Rønsholt, L. (2000) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(00)00226-9 · Cited by 249 · cited 1×
“tions (302, 308), and elevations in levels of serum acute-phase response proteins (171).”
BackgroundHARRISON, A. M., BONVILLE, C. A., ROSENBERG, H. F., & DOMACHOWSKE, J. B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9805083 · Cited by 245 · cited 4×
“degranulation products (169) and with severity of disease”
BackgroundInfluentialSelf-citationA Randomized Trial of Montelukast in Respiratory Syncytial Virus Postbronchiolitis
Bisgaard, H. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-747oc · Cited by 245 · cited 2×
“cells spontaneously formed nucleocapsid structures containing RNA (24).”
BackgroundMelero, J. A., Cane, P. A., Mart√≠nez, I., Pringle, C. R., & García‐Barreno, B. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-10-2411 · Cited by 243 · cited 1×
“The immune response to hRSV correlates with and provides selection pressure for G-protein variation (127, 261).”
BackgroundSurfactant Protein D Gene Polymorphism Associated with Severe Respiratory Syncytial Virus Infection
Lahti, M., Löfgren, J., Marttila, R., Renko, M., Klaavuniemi, T., Haataja, R., Rämet, M., & Hallman, M. (2002) · Pediatric Research · doi:10.1203/00006450-200206000-00006 · Cited by 242 · cited 1×
“results, Hallman and colleagues (223, 239) have documented correlations between specific alleles of the genes encoding”
BackgroundSchlender, J., Bossert, B., Buchholz, U., & Conzelmann, K.-K. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8234-8242.2000 · Cited by 242 · cited 5×
“alone (315), suggesting that the NS1 and NS2 proteins function together to inhibit responses to interferon in this setting.”
BackgroundInfluentialGonzález-Reyes, L., Ruiz-Argüello, M. B., García-Barreno, B., Calder, L., López, J. A., Albar, J. P., Skehel, J. J., Wiley, D. C., & Melero, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151098198 · Cited by 242 · cited 1×
“cleavage into two disulfide-linked subunits, F1 and F2, at two furin consensus sites (142, 392, 393).”
BackgroundNosocomial Respiratory Syncytial Virus Infections: The "Cold War" Has Not Ended
Hall, C. B. (2000) · Clinical Infectious Diseases · doi:10.1086/313960 · Cited by 241
Haeberle, H. A., Takizawa, R., Casola, A., Brasier, A. R., Dieterich, H., van Rooijen, N., Gatalica, Z., & Garofalo, R. P. (2002) · The Journal of Infectious Diseases · doi:10.1086/344644 · Cited by 237 · cited 1×
“in innate host defense against hRSV in vivo (158, 170, 222).”
BackgroundPresence of the new human metapneumovirus in French children with bronchiolitis
Freymuth, F., Vabret, A., Legrand, L., Eterradossi, N., Lafay-Delaire, F., Brouard, J., & Guillois, B. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200301000-00024 · Cited by 237 · cited 2×
“ports have associated hMPV infection with asthma exacerbation (123, 187, 247, 337), one report suggests that the associ-”
BackgroundWhitehead, S. S., Bukreyev, A., Teng, M. N., Firestone, C.-Y., St. Claire, M., Elkins, W. R., Collins, P. L., & Murphy, B. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3438-3442.1999 · Cited by 237 · cited 2×
“Teng, Whitehead, and colleagues (346, 378) have demonstrated the attenuation of hRSV NS-1 and M2-2 or NS-1 and SII deletion mutants in the chimpanzee model of infection, although without specific reference to interferonrelated phenomena.”
BackgroundHallak, L. K., Collins, P. L., Knudson, W., & Peeples, M. E. (2000) · Virology · doi:10.1006/viro.2000.0293 · Cited by 234 · cited 2×
“(163, 164) reported that only N-sulfated moieties of GAGs (and not C6-O or C2-O sulfation) are important mediators of RSV infection and later documented the specific role of iduronic acid-substi-”
BackgroundHeparin-dependent attachment ofrespiratory syncytial virus (RSV) to host cells
Krusat, T., & Streckert, H. J. (1997) · Archives of Virology · doi:10.1007/s007050050156 · Cited by 226 · cited 2×
“Among the earliest findings, Krusat and Streckert (218) demonstrated that the glycosaminoglycan (GAG) heparin, when included in an in vitro culture system, could inhibit the infection of target cells with hRSV.”
BackgroundGarcı́a, J., Garcı́a-Barreno, B., Vivo, A., & Melero, J. A. (1993) · Virology · doi:10.1006/viro.1993.1366 · Cited by 226 · cited 1×
“Immunocytochemical analysis of cytoplasmic inclusions showed that genome RNA, N, P, L, and M2-1 proteins were colocalized in hRSV-infected cells (126).”
BackgroundGrosfeld, H., Hill, M. G., & Collins, P. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5677-5686.1995 · Cited by 226 · cited 1×
“, proteins that must be added for efficient first-round virus replication) are the N, P, and L proteins, the presence of the M2 gene significantly enhanced the production of full length virus mRNA (62, 63, 112, 152, 388).”
BackgroundTeng, M. N., Whitehead, S. S., & Collins, P. L. (2001) · Virology · doi:10.1006/viro.2001.1138 · Cited by 225 · cited 3×
“(347) later demonstrated that deletion of the G-protein binding domain did not alter sensitivity”
BackgroundGarofalo, R. P., Patti, J., Hintz, K. A., Hill, V., Ogra, P. L., & Welliver, R. C. (2001) · The Journal of Infectious Diseases · doi:10.1086/322788 · Cited by 222
Whimbey, E. E., Champlin, R. E., Englund, J. A., Mirza, N. Q., Piedra, P. A., Goodrich, J. M., Przepiorka, D., Luna, M. A., Morice, R. C., & Neumann, J. L. (1995) · PubMed · Cited by 222
Molecular mimicry and the generation of host defense protein diversity
MURPHY, P. (1993) · Cell · doi:10.1016/0092-8674(93)90571-7 · Cited by 218
Zhang, Y., Luxon, B. A., Casola, A., Garofalo, R. P., Jamaluddin, M., & Brasier, A. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9044-9058.2001 · Cited by 217 · cited 1×
“(390), presents an evaluation of the responses of the human epithelial cell line A549 and primary human SAE cells to infection with the A2 strain of RSV.”
BackgroundGarofalo, R., Sabry, M., Jamaluddin, M., Yu, R. K., Casola, A., Ogra, P. L., & Brasier, A. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8773-8781.1996 · Cited by 213 · cited 1×
“NF- B (119, 135, 253, 255), with the involvement of NF-IL-6”
Unusual Haplotypic Structure of IL8, a Susceptibility Locus for a Common Respiratory Virus
Hull, J., Ackerman, H., Isles, K., Usen, S., Pinder, M., Thomson, A., & Kwiatkowski, D. (2001) · The American Journal of Human Genetics · doi:10.1086/321291 · Cited by 209 · cited 1×
“kowski and colleagues (177, 178) have provided evidence supporting a relationship between disease and a susceptibility lo-”
BackgroundKarron, R. A., Wright, P. F., Crowe, Jr., Clements‐Mann, M. L., Thompson, J., Makhene, M., Casey, R., & Murphy, B. R. (1997) · The Journal of Infectious Diseases · doi:10.1086/514138 · Cited by 208 · cited 1×
“Currently, two promising candidate vaccines under study in clinical trials are an hRSV F subunit vaccine for immunization of patients who have already experienced primary RSV infection, such as the elderly and older hRSV-seropositive children with conditions predisposing them to severe hRSV disease (108, 279, 288, 354…”
BackgroundTeng, M. N., Whitehead, S. S., Bermingham, A., St. Claire, M., Elkins, W. R., Murphy, B. R., & Collins, P. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9317-9321.2000 · Cited by 202 · cited 1×
“Teng, Whitehead, and colleagues (346, 378) have demonstrated the attenuation of hRSV NS-1 and M2-2 or NS-1 and SII deletion mutants in the chimpanzee model of infection, although without specific reference to interferonrelated phenomena.”
BackgroundEvidence of human metapneumovirus in Australian children
Nissen, M. D., Mackay, I. M., Withers, S. J., Siebert, D. J., & Sloots, T. P. (2002) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04354.x · Cited by 199 · cited 1×
“(360), and evidence of infection has since been collected worldwide (26, 105, 110, 273, 286), with one reported fatality in a stem cell transplant recipient (44).”
BackgroundParamyxoviridae Use Distinct Virus-Specific Mechanisms to Circumvent the Interferon Response
Young, D. F., Didcock, L., Goodbourn, S., & Randall, R. E. (2000) · Virology · doi:10.1006/viro.2000.0240 · Cited by 196
Transmission of viral respiratory infections in the home
GOLDMANN, D. A. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200010001-00002 · Cited by 196 · cited 1×
“The clinical signs and symptoms of acute hRSV infection have been described in significant detail in several recent reviews (86, 141, 155, 161, 162, 216, 372).”
BackgroundHoebee, B., Rietveld, E., Bont, L., Oosten, M. V., Hodemaekers, H. M., Nagelkerke, N. J. D., Neijens, H. J., Kimpen, J. L. L., & Kimman, T. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/345859 · Cited by 191
Johnson, T. R., Johnson, J. E., Roberts, S. R., Wertz, G. W., Parker, R. A., & Graham, B. S. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2871-2880.1998 · Cited by 189 · cited 1×
“The function of the secreted protein is not known, but it may alter the immune response of the host, possibly by acting as a “decoy” or by altering specific aspects of the host inflammatory response (190, 191).”
BackgroundSystemic Corticosteroids in Infant Bronchiolitis: A Meta-analysis
Garrison, M. M., Christakis, D. A., Harvey, E., Cummings, P., & Davis, R. L. (2000) · Pediatrics · doi:10.1542/peds.105.4.e44 · Cited by 189 · cited 1×
“29 day per patient when patients with previous episodes of wheezing were excluded from the analysis (137), a”
BackgroundLöfgren, J., Rämet, M., Renko, M., Marttila, R., & Hallman, M. (2002) · The Journal of Infectious Diseases · doi:10.1086/338473 · Cited by 186 · cited 1×
“results, Hallman and colleagues (223, 239) have documented correlations between specific alleles of the genes encoding”
BackgroundHeparan sulfate: Anchor for viral intruders?
Spillmann, D. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01290-1 · Cited by 181
Molecular Assays for Detection of Human Metapneumovirus
Mackay, I. M., Jacob, K. C., Woolhouse, D., Waller, K., Syrmis, M. W., Whiley, D. M., Siebert, D. J., Nissen, M., & Sloots, T. P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.100-105.2003 · Cited by 181 · cited 3×
“amount of virus gene sequence that is available (18, 245, 360, 361).”
BackgroundHardy, R. W., & Wertz, G. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.520-526.1998 · Cited by 178
Viral infections in interferon-γ receptor deficiency
Dorman, S. E., Uzel, G., Roesler, J., Bradley, J. S., Bastian, J., Billman, G., King, S., Filie, A., Schermerhorn, J., & Holland, S. M. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70064-8 · Cited by 177
Simoes, E. A. F., Sondheimer, H. M., Top, F. H., Meissner, H. C., Welliver, R. C., Kramer, A. A., & Groothuis, J. R. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70056-3 · Cited by 176
García-Barreno, B., Palomo, C., Peñas, C., Delgado, T., Perez-Breña, P., & Melero, J. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.925-932.1989 · Cited by 175
Haeberle, H. A., Kuziel, W. A., Dieterich, H.-J., Casola, A., Gatalica, Z., & Garofalo, R. P. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.878-890.2001 · Cited by 174 · cited 1×
“(157), who evaluated the responses of inoculated BALB/c mice, although the latter group also reported the inducible expression of MIP-1 .”
BackgroundBossert, B., Marozin, S., & Conzelmann, K.-K. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8661-8668.2003 · Cited by 173 · cited 3×
“(31) have demonstrated that NS1 and NS2 proteins inhibit the activation of interferon regulatory factor 3 and thus the production of beta interferon in bRSV- infected MDBK cells.”
BackgroundThe Role of IFN in Respiratory Syncytial Virus Pathogenesis
Durbin, J. E., Johnson, T. R., Durbin, R. K., Mertz, S. E., Morotti, R. A., Peebles, R. S., & Graham, B. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2944 · Cited by 173 · cited 1×
“Interestingly, hRSV is sensitive to inhibition by gamma interferon (11, 20, 39, 99, 276, 365), and potential hRSV-mediated modulation pathways have been”
BackgroundChoi, E. H., Lee, H. J., Yoo, T., & Chanock, S. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/344310 · Cited by 172
Asthma Exacerbations in Children Associated with Rhinovirus but not Human Metapneumovirus Infection
Rawlinson, W. D., Waliuzzaman, Z., Carter, I. W., Belessis, Y. C., Gilbert, K. M., & Morton, J. R. (2003) · The Journal of Infectious Diseases · doi:10.1086/368411 · Cited by 172
Selected populations at increased risk from respiratory syncytial virus infection
MEISSNER, H. C. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000053884.21238.13 · Cited by 172
Halsey, N. A., Chesney, P. J., Gerber, M. A., Gromisch, D. S., Kohl, S., Marcy, S. M., Marks, M. I., Murray, D. L., Overall, J. C., Pickering, L. K., et al. (1996) · PubMed · Cited by 172
Heparan sulfate fine structure and specificity of proteoglycan functions
Nakato, H., & Kimata, K. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00398-7 · Cited by 162
Johnson, T. R., & Graham, B. S. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8485-8495.1999 · Cited by 162 · cited 1×
“The function of the secreted protein is not known, but it may alter the immune response of the host, possibly by acting as a “decoy” or by altering specific aspects of the host inflammatory response (190, 191).”
BackgroundRoberts, S. R., Lichtenstein, D., Ball, L. A., & Wertz, G. W. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4538-4546.1994 · Cited by 161
Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells
Roberts, S. R., Compans, R. W., & Wertz, G. W. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2667-2673.1995 · Cited by 160
Domachowske, J. B., Bonville, C. A., Gao, J.-L., Murphy, P. M., Easton, A. J., & Rosenberg, H. F. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2677 · Cited by 159 · cited 2×
“However, others have shown that while MIP-1 is produced in this model, the levels detected do not correlate with the extent of the inflammatory response (89), as has been observed in both human disease (136, 169) and the PVM mouse model (90).”
BackgroundSelf-citationProteolytic Activation of Respiratory Syncytial Virus Fusion Protein
Zimmer, G., Budz, L., & Herrler, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102633200 · Cited by 159 · cited 1×
“cleavage into two disulfide-linked subunits, F1 and F2, at two furin consensus sites (142, 392, 393).”
BackgroundYu, Q., Hardy, R. W., & Wertz, G. W. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2412-2419.1995 · Cited by 158 · cited 1×
“, proteins that must be added for efficient first-round virus replication) are the N, P, and L proteins, the presence of the M2 gene significantly enhanced the production of full length virus mRNA (62, 63, 112, 152, 388).”
BackgroundCane, P. A., van den Hoogen, B. G., Chakrabarti, S., Fegan, C., & Osterhaus, A. D. M. E. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703849 · Cited by 157 · cited 1×
“(360), and evidence of infection has since been collected worldwide (26, 105, 110, 273, 286), with one reported fatality in a stem cell transplant recipient (44).”
BackgroundRespiratory syncytial virus and other respiratory viruses
Welliver, C. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000053880.92496.db · Cited by 156 · cited 1×
“The clinical signs and symptoms of acute hRSV infection have been described in significant detail in several recent reviews (86, 141, 155, 161, 162, 216, 372).”
BackgroundRespiratory Syncytial Virus—Viral Biology and the Host Response
Hacking, D., & Hull, J. (2002) · Journal of Infection · doi:10.1053/jinf.2002.1015 · Cited by 155
Malhotra, R., Ward, M. A., Bright, H., Priest, R. C., Foster, M. R., Hurle, M., Blair, E., & Bird, M. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(02)00079-5 · Cited by 154 · cited 1×
“(246) suggests a role for annexin II, which itself is a heparin binding protein and as such may interact with the glycosylated virus proteins and glycosylated target cell proteins in unexplored and unexpected ways.”
BackgroundNebulized Budesonide and Oral Dexamethasone for Treatment of Croup: A Randomized Controlled Trial
Klassen, T. P., Craig, W. R., Moher, D., Osmond, M. H., Pasterkamp, H., Sutcliffe, T., Watters, L. K., & Rowe, P. C. (1998) · JAMA · doi:10.1001/jama.279.20.1629 · Cited by 154
Klassen, T. P., Sutcliffe, T., Watters, L. K., Wells, G. A., Allen, U., & Li, M. M. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70342-1 · Cited by 153 · cited 1×
“Unfortunately, these trials suggest that when used alone in the absence of antivirals, glucocorticoid treatment has only marginal, if any, benefit in the treatment of hRSV-infection and its associated inflammatory response (72, 83, 84, 212, 213, 231, 307, 331, 334, 338, 365).”
BackgroundMart√≠nez, I., Melero, J. A., & Dopazo, J. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-10-2419 · Cited by 152 · cited 1×
“Escape mutants have been created from hRSV grown in tissue culture in the presence of neutralizing monoclonal antibodies directed against the virus G or F proteins (241, 252, 253, 368).”
BackgroundSchwarze, J., Cieslewicz, G., Hamelmann, E. H., Joetham, A., Shultz, L. D., Lamers, M. C., & Gelfand, E. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2997 · Cited by 152 · cited 1×
“All describe the moderate influx of inflammatory cells, with reports including lymphocytes and eosinophils as components of the respiratory infiltrates (120, 145, 147, 319, 320).”
BackgroundMastronarde, J. G., He, R., Monick, M. M., Mukaida, N., Matsushima, K., & Hunninghake, G. W. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.2.262 · Cited by 151 · cited 1×
“(185, 254), ERK-2 (53), and unique hRSV-responding enhancer elements in the IL-8 gene promoter (48).”
BackgroundBossert, B., & Conzelmann, K.-K. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4287-4293.2002 · Cited by 149 · cited 2×
“Among the results as they relate to disease pathogenesis are the finding that the bRSV NS1 and NS2 proteins function in synchrony to antagonize alpha/beta interferon-mediated antiviral activities in a species-specific fashion (30, 315) and that the SH and G genes are dispensable for bRSV replication in vitro (204).”
BackgroundRespiratory syncytial virus matrix protein associates with nucleocapsids in infected cells
Ghildyal, R., MILLS, J. S., Murray, M., Vardaxis, N. J., & Meanger, J. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-4-753 · Cited by 148
Valarcher, J., Furze, J. M., Wyld, S. G., Cook, R. S., Conzelmann, K., & Taylor, G. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8426-8439.2003 · Cited by 148 · cited 2×
“(358) likewise demonstrated that recombinant, NS-2 lacking, bRSV are potent inducers of interferon in bovine nasal fibroblasts and bron-”
BackgroundA bovine model of vaccine enhanced respiratory syncytial virus pathophysiology
Gershwin, L. J., Schelegle, E. S., Gunther, R. A., Anderson, M. L., Woolums, A. R., Larochelle, D., Boyle, G. A., Friebertshauser, K. E., & Singer, R. S. (1998) · Vaccine · doi:10.1016/s0264-410x(98)80123-0 · Cited by 145 · cited 1×
“There is some information relating to a potential immunopotentiation in response to challenge after formalin-inactivated vaccine administration (138, 318), analogous to what was ob-”
ResultEvolution of Bovine Respiratory Syncytial Virus
Valarcher, J., Schelcher, F., & Bourhy, H. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10714-10728.2000 · Cited by 144 · cited 1×
“One study has documented sequence clustering based on geography (357), while yet another reports extensive sequence divergence in outbreaks distributed over time within a single herd (228).”
BackgroundPiedra, P. A., Grace, S. C., Jewell, A. M., Spinelli, S. H., BUNTING, D., HOGERMAN, D. A., Malinoski, F. J., & Hiatt, P. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199601000-00006 · Cited by 140 · cited 1×
“Currently, two promising candidate vaccines under study in clinical trials are an hRSV F subunit vaccine for immunization of patients who have already experienced primary RSV infection, such as the elderly and older hRSV-seropositive children with conditions predisposing them to severe hRSV disease (108, 279, 288, 354…”
BackgroundSequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains
Bastien, N., Normand, S., Taylor, T., Ward, D., Peret, T. C. T., Boivin, G., Anderson, L. J., & Li, Y. (2003) · Virus Research · doi:10.1016/s0168-1702(03)00065-0 · Cited by 140 · cited 2×
“The intergenic regions of the pneumoviruses are variable in length and tolerate mutation and insertion of additional nucleotides (18, 42, 49, 361).”
BackgroundSignificant differences in nucleocapsid morphology within the Paramyxoviridae
Bhella, D., Ralph, A., Murphy, L. B., & Yeo, R. P. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-8-1831 · Cited by 140 · cited 8×
“While the RSV N protein (391 amino acids) is smaller than its counterparts among the Paramyxovirinae (489 to 553 amino acids) and shows little sequence similarity, alignments with the amino-terminal 400 amino acids of the N proteins of various nonsegmented negative-sense RNA viruses suggested similarities among predic…”
BackgroundInfluentialRodriguez, W. J., Gruber, W. C., Groothuis, J. R., Simões, E. A. F., Rosas, A. J., LEPOW, M. L., Kramer, A. A., Hemming, V. G., & the RSV-IGIV Study Group (1997) · PEDIATRICS · doi:10.1542/peds.100.6.937 · Cited by 139 · cited 1×
“adverse events between the two groups (306).”
Identification of NF-κB-Dependent Gene Networks in Respiratory Syncytial Virus-Infected Cells
Tian, B., Zhang, Y., Luxon, B. A., Garofalo, R. P., Casola, A., Sinha, M., & Brasier, A. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6800-6814.2002 · Cited by 138 · cited 1×
“The second publication focused on the in vitro response (349) has provided us with a more general look at the responses directly related to the activation of the proinflammatory transcriptional master switch, NF- B.”
BackgroundBovine Respiratory Syncytial Virus (BRSV): A review
Larsen, L. E. (2000) · Acta veterinaria Scandinavica · doi:10.1186/bf03549652 · Cited by 138
Ribavirin for Respiratory Syncytial Virus Lower Respiratory Tract Infection: A Systematic Overview
Randolph, A. G., & Wang, E. E. (1996) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1996.02170340056011 · Cited by 137
Stec, D. S., Hill, M. G., & Collins, P. L. (1991) · Virology · doi:10.1016/0042-6822(91)90140-7 · Cited by 136 · cited 1×
“The PVM transcriptional start signals are more variable than those of RSV or APV, which are absolutely conserved with the exception of the L gene (49, 296, 332).”
BackgroundParamyxovirus Accessory Proteins as Interferon Antagonists
Gotoh, B., Komatsu, T., Takeuchi, K., & Yokoo, J. (2001) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2001.tb01315.x · Cited by 132
Murphy, B. R., Hall, S. L., Kulkarni, A. B., Crowe, J. E., Collins, P. L., Connors, M., Karron, R. A., & Chanock, R. M. (1994) · Virus Research · doi:10.1016/0168-1702(94)90059-0 · Cited by 131 · cited 1×
“Furthermore, newborns and very young infants may not mount a protective immune response because of relative immunologic immaturity or suppression of their immune response due to circulating maternally derived antihRSV antibodies (68, 79, 108, 267).”
BackgroundImmune-mediated disease pathogenesis in respiratory syncytial virus infection
Graham, B. S., Johnson, T. R., & Peebles, R. S. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00233-2 · Cited by 130 · cited 1×
“The postvaccination response has been characterized extensively, and the profound lymphocytic and eosinophilic inflammation observed has been attributed to an induced Th1-Th2 imbalance, with dominance of Th2 lymphocyte responses in this setting (32, 148, 180).”
BackgroundMastronarde, J. G., Monick, M. M., Mukaida, N., Matsushima, K., & Hunninghake, G. W. (1998) · The Journal of Infectious Diseases · doi:10.1086/515279 · Cited by 130 · cited 1×
“NF- B (119, 135, 253, 255), with the involvement of NF-IL-6”
IL‐8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis
Abu-Harb, M., Bell, F., Finn, A. H. R., Rao, W., Nixon, L. S., Shale, D. J., & Everard, M. L. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14a23.x · Cited by 129 · cited 1×
“tory secretions and in bronchoalveolar lavage samples from individuals infected with hRSV (1, 169, 182, 263).”
BackgroundCELL-MEDIATED CYTOTOXIC RESPONSE TO RESPIRATORY SYNCYTIAL VIRUS IN INFANTS WITH BRONCHIOLITIS
Isaacs, D., Bangham, C. R. M., & McMichael, A. J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92502-5 · Cited by 128 · cited 1×
“Virus-specific cytotoxic T lymphocytes have been detected within 10 days of infection in human subjects (54, 181), and roles for CD4 and CD8 T lymphocytes in virus”
BackgroundInfluence of Maternal Antibodies on Neonatal Immunization against Respiratory Viruses
Crowe, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/322971 · Cited by 127 · cited 1×
“Furthermore, newborns and very young infants may not mount a protective immune response because of relative immunologic immaturity or suppression of their immune response due to circulating maternally derived antihRSV antibodies (68, 79, 108, 267).”
BackgroundMorphogenesis and Ultrastructure of Respiratory Syncytial Virus
Bächi, T., & Howe, C. (1973) · Journal of Virology · doi:10.1128/jvi.12.5.1173-1180.1973 · Cited by 126 · cited 1×
“Virions, while pleomorphic, are typically spherical (diameters of 150 to 200 nm), although filamentous particles of up to 400 nm in length have been described (9, 22, 192).”
BackgroundAntiviral Activity of Lovastatin against Respiratory Syncytial Virus In Vivo and In Vitro
Gower, T. L., & Graham, B. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1231-1237.2001 · Cited by 126 · cited 1×
“(383), eosinophil-derived neurotoxin, a potent RNase (87), and lovastatin (144).”
BackgroundTristram, D. A., Welliver, C., Mohar, C. K., HOGERMAN, D. A., Hildreth, S. W., & Paradiso, P. R. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.1.191 · Cited by 126
Siber, G. R., Leombruno, D., Leszczynski, J., McIver, J., Bodkin, D. K., Gonin, R., Thompson, C. M., Walsh, E. E., Piedra, P. A., Hemming, V. G., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.6.1368 · Cited by 125 · cited 1×
“The earliest studies with experimental animals suggested that immunoglobulin preparations containing high-titer antibodies to hRSV (hRSV-Ig) protected against development of severe disease (150, 291, 323).”
BackgroundLeucocyte populations in respiratory syncytial virus‐induced bronchiolitis
Smith, P., Wang, S.-Z., Dowling, K. D., & Forsyth, K. D. (2001) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2001.00618.x · Cited by 124 · cited 1×
“While lymphocytes were predominant in postmortem specimens, more recent studies have pointed to neutrophil influx as an earlier acute cellular response and to neutrophil-mediated activities as a major cause of respiratory symptoms (107, 209, 328, 370).”
BackgroundAntigenic Structure of Human Respiratory Syncytial Virus Fusion Glycoprotein
López, J. A., Bustos, R., Örvell, C., Berois, M., Arbiza, J., García-Barreno, B., & Melero, J. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6922-6928.1998 · Cited by 123 · cited 1×
“Escape mutants have been created from hRSV grown in tissue culture in the presence of neutralizing monoclonal antibodies directed against the virus G or F proteins (241, 252, 253, 368).”
BackgroundOstler, T., Davidson, W. F., & Ehl, S. R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200208)32:8<2117::aid-immu2117>3.0.co;2-c · Cited by 123 · cited 1×
“Interestingly, hRSV is sensitive to inhibition by gamma interferon (11, 20, 39, 99, 276, 365), and potential hRSV-mediated modulation pathways have been”
BackgroundDetection and differentiation of avian pneumoviruses (metapneumoviruses)
Cook, J. K. A., & Cavanagh, D. (2002) · Avian Pathology · doi:10.1080/03079450120118603 · Cited by 120
Techaarpornkul, S., Collins, P. L., & Peeples, M. E. (2002) · Virology · doi:10.1006/viro.2001.1340 · Cited by 118 · cited 1×
“While the precise nature of the cellular receptor has not been identified, current evidence suggests that one or more cellular glycosaminoglycans or heparin-like molecules are involved (116, 163, 164, 218, 342).”
BackgroundZhang, Y., Jamaluddin, M., Wang, S., Tian, B., Garofalo, R. P., Casola, A., & Brasier, A. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5933-5947.2003 · Cited by 118 · cited 3×
“gene microarray (391) and mouse model (27, 29) studies sug-”
Backgroundvan Schaik, S. M., Obot, N., Enhorning, G., Hintz, K., Gross, K., Hancock, G. E., Stack, A. M., & Welliver, R. C. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200010)62:2<257::aid-jmv19>3.0.co;2-m · Cited by 117
Teng, M. N., & Collins, P. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.466-473.1999 · Cited by 116 · cited 1×
“tants were attenuated in chimpanzees (188, 344, 347, 378).”
BackgroundReplication and Clearance of Respiratory Syncytial Virus
Viuff, B. M., Tjørnehøj, K., Larsen, L. E., Røntved, C. M., Uttenthal, Å., Rønsholt, L., & Alexandersen, S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64496-3 · Cited by 113 · cited 1×
“toms of lower respiratory tract infection (287, 350, 367, 380).”
BackgroundWeisman, L. E. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000053883.08663.e5 · Cited by 111
Falsey, A. R., & Walsh, E. E. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00030-8 · Cited by 110
Fischer, J. E., Johnson, J. E., Kuli-Zade, R. K., Johnson, T. R., Aung, S., Parker, R. A., & Graham, B. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8672-8677.1997 · Cited by 110 · cited 1×
“All describe the moderate influx of inflammatory cells, with reports including lymphocytes and eosinophils as components of the respiratory infiltrates (120, 145, 147, 319, 320).”
BackgroundAntiviral properties of extract of opuntia streptacantha
AHMAD, A., Davies, J., Randall, S., & Skinner, G. R. B. (1996) · Antiviral Research · doi:10.1016/0166-3542(95)00839-x · Cited by 109 · cited 1×
“crude plant protein extracts (3), some forms of superoxide dismutase (384), an L-aspartate transcarbamoylase inhibitor”
BackgroundFalsey, A. R., & Walsh, E. E. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00002-9 · Cited by 109 · cited 1×
“Several strategies have been implemented recently in an attempt to generate safe and effective subunit, inactivated, and live-attenuated hRSV vaccines (60, 109).”
BackgroundGarofalo, R. P., Mei, F. C., Espejo, R. A., Ye, G., Haeberle, H. A., Baron, S., Ogra, P. L., & Reyes, V. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2506 · Cited by 107
Early ribavirin treatment of respiratory syncytial viral infection in high-risk children
Groothuis, J. R., Woodin, K. A., KATZ, R. W., Robertson, A. D., McBride, J. T., Hall, C. B., McWilliams, B., & Lauer, B. A. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83347-5 · Cited by 107
Ling, R., Easton, A. J., & Pringle, C. R. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-7-1709 · Cited by 104
Self-citationCasola, A., Garofalo, R. P., Jamaluddin, M., Vlahopoulos, S., & Brasier, A. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5944 · Cited by 103 · cited 1×
“(185, 254), ERK-2 (53), and unique hRSV-responding enhancer elements in the IL-8 gene promoter (48).”
BackgroundGenetic Recombination during Coinfection of Two Mutants of Human Respiratory Syncytial Virus
Spann, K. M., Collins, P. L., & Teng, M. N. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11201-11211.2003 · Cited by 103
Tripp, R. A., Jones, L. P., & Anderson, L. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.6227-6229.2000 · Cited by 102 · cited 1×
“have also been implicated in impairing the Th1-mediated host antiviral responses (352).”
BackgroundParadiso, P. R., Hildreth, S. W., HOGERMAN, D. A., Speelman, D. J., Lewin, E. B., Oren, J., & Smith, D. H. (1994) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199409000-00008 · Cited by 99
Bartz, H., Türkel, Ö., Hoffjan, S., Rothoeft, T., Gonschorek, A., & Schauer, U. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01629.x · Cited by 98
Bovine Respiratory Syncytial Virus
Baker, J. C., Ellis, J., & Clark, E. G. (1997) · Veterinary Clinics of North America Food Animal Practice · doi:10.1016/s0749-0720(15)30307-8 · Cited by 97
Chiba, Y., Higashidate, Y., Suga, K., Honjo, K., Tsutsumi, H., & Ogra, P. L. O. (1989) · Journal of Medical Virology · doi:10.1002/jmv.1890280304 · Cited by 95 · cited 1×
“Virus-specific cytotoxic T lymphocytes have been detected within 10 days of infection in human subjects (54, 181), and roles for CD4 and CD8 T lymphocytes in virus”
BackgroundThe Immunology of the Bovine Respiratory Disease Complex
Ellis, J. A. (2001) · Veterinary Clinics of North America: Food Animal Practice · doi:10.1016/s0749-0720(15)30005-0 · Cited by 94
bovine respiratory syncytial virus
CABI (2019) · CABI Compendium · doi:10.1079/cabicompendium.91738 · Cited by 94
Mink, M. A., Stec, D. S., & Collins, P. L. (1991) · Virology · doi:10.1016/0042-6822(91)90532-g · Cited by 92
Atreya, P. L., & Kulkarni, S. (1999) · Virology · doi:10.1006/viro.1999.9835 · Cited by 91 · cited 2×
“Given that there is ample evidence for induced production of beta interferon by hRSV-infected epithelial cells (7, 134, 186, 356), the question of resistance remains acute.”
BackgroundCollins, P. L., Olmsted, R. A., Spriggs, M. K., Johnson, P. R., & Buckler-White, A. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5134 · Cited by 87 · cited 3×
“Thus, a large proportion of the mRNA initiated at the L-gene start sequence terminates at the M2 transcriptional stop sequence (65, 111).”
BackgroundCollins, P. L., Whitehead, S. S., Bukreyev, A. A., Fearns, R., Teng, M. N., Juhász, K., Chanock, R. M., & Murphy, B. R. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60374-7 · Cited by 87 · cited 1×
“its application to the vaccine effort (60, 69, 268) have recently been reviewed.”
BackgroundBehera, A. K., Kumar, M., Lockey, R. F., & Mohapatra, S. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200211200 · Cited by 85
Blanco, J. C. G., Richardson, J. Y., Darnell, M. E. R., Rowzee, A. M., Pletneva, L. M., Porter, D. D., & Prince, G. A. (2002) · The Journal of Infectious Diseases · doi:10.1086/340823 · Cited by 84 · cited 1×
“(25) documented the increased expression of transcripts encoding several cytokines, chemokines, alpha and gamma interferons, and the interferon response gene, IP-10, in response to inoculation of cotton rats with 10(5) PFU of hRSVA Long strain.”
BackgroundSchreiber, P., Matheise, J.-P., Dessy, F. J., Heimann, M., Letesson, J., Coppe, P., & Collard, A. (2000) · Journal of Veterinary Medicine Series B · doi:10.1046/j.1439-0450.2000.00380.x · Cited by 84 · cited 1×
“There is some information relating to a potential immunopotentiation in response to challenge after formalin-inactivated vaccine administration (138, 318), analogous to what was ob-”
ResultSchwarze, J., Cieslewicz, G., Joetham, A., Ikemura, T., Mäkelä, M. J., Dakhama, A., Shultz, L. D., Lamers, M. C., & Gelfand, E. W. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9903057 · Cited by 83 · cited 1×
“All describe the moderate influx of inflammatory cells, with reports including lymphocytes and eosinophils as components of the respiratory infiltrates (120, 145, 147, 319, 320).”
BackgroundMurphy, B. R., & Collins, P. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16077 · Cited by 83 · cited 1×
“its application to the vaccine effort (60, 69, 268) have recently been reviewed.”
BackgroundRFI-641, a Potent Respiratory Syncytial Virus Inhibitor
Huntley, C. C., Weiss, W. J., Gazumyan, A., Buklan, A., Feld, B., Hu, W. K., Jones, T. R., Murphy, T., Nikitenko, A. A., O’Hara, B., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.841-847.2002 · Cited by 81 · cited 1×
“vitro and in vivo via blockade of cell-cell fusion (179, 258, 272), while a benzodithiin compound has demonstrated ability to”
BackgroundWoelk, C. H., & Holmes, E. C. (2001) · Journal of Molecular Evolution · doi:10.1007/s002390010147 · Cited by 80
West, K. H., Petrie, L., Konoby, C., Haines, D. M., Cortese, V. S., & Ellis, J. A. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00324-2 · Cited by 79 · cited 2×
“There are several vaccine formulations in existence—modified live and inactivated, in both adjuvanted and nonadjuvanted forms (102, 374, 375)—and there is significant debate about the relative efficacy and modes of appropriate response.”
BackgroundJamaluddin, M., Wang, S., Garofalo, R. P., Elliott, T., Casola, A., Baron, S., & Brasier, A. R. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.2.l248 · Cited by 79
Buchholz, U. J., Granzow, H., Schuldt, K., Whitehead, S. S., Murphy, B. R., & Collins, P. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1187-1199.2000 · Cited by 78 · cited 1×
“This technology has already been applied to the development of the next generation of bRSV and hRSV vaccines (36, 317).”
MethodThe interaction of neutrophils with respiratory epithelial cells in viral infection
Wang, S., & Forsyth, K. D. (2000) · Respirology · doi:10.1046/j.1440-1843.2000.00219.x · Cited by 77 · cited 1×
“While lymphocytes were predominant in postmortem specimens, more recent studies have pointed to neutrophil influx as an earlier acute cellular response and to neutrophil-mediated activities as a major cause of respiratory symptoms (107, 209, 328, 370).”
BackgroundMetapneumoviruses in birds and humans
Njenga, M. K., Lwamba, H. M., & Seal, B. S. (2003) · Virus Research · doi:10.1016/s0168-1702(02)00256-3 · Cited by 77
Domachowske, J. B., Bonville, C. A., Dyer, K. D., Easton, A. J., & Rosenberg, H. F. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1620 · Cited by 77 · cited 1×
“Eosinophils are also recruited to the lungs in response to primary hRSV bronchiolitis (133, 169), and both neutrophils and eosinophils are recruited to lung tissue in the PVM model of acute pneumovirus infection in vivo (88).”
BackgroundSelf-citationRespiratory Syncytial Virus: Reverse Genetics and Vaccine Strategies
Collins, P. L., & Murphy, B. R. (2002) · Virology · doi:10.1006/viro.2002.1437 · Cited by 76 · cited 2×
“its application to the vaccine effort (60, 69, 268) have recently been reviewed.”
BackgroundKAO, Y. J., PIEDRA, P. A., LARSEN, G. L., & COLASURDO, G. N. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.9912068 · Cited by 76
Bukreyev, A. A., Belyakov, I. M., Berzofsky, J. A., Murphy, B. R., & Collins, P. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12128-12140.2001 · Cited by 76
Follett, E. A. C., Pringle, C. R., & Pennington, T. H. (1975) · Journal of General Virology · doi:10.1099/0022-1317-26-2-183 · Cited by 75 · cited 1×
“While pneumovirus infection results in alteration of host cell gene expression, there is no absolute requirement for a functional nucleus, since virus development can proceed in enucleated cells (122).”
BackgroundHuman metapneumovirus: a newly emerging respiratory pathogen
Kahn, J. S. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200306000-00012 · Cited by 75
Chen, W., Monick, M. M., Carter, A. B., & Hunninghake, G. W. (2000) · Experimental Lung Research · doi:10.1080/019021400269934 · Cited by 73 · cited 2×
“The transcriptional control of IL-8 relies on the activation of the master transcriptional activator, NF- B (119, 135, 253, 255), with the involvement of NF-IL-6 (185, 254), ERK-2 (53), and unique hRSV-responding enhancer elements in the IL-8 gene promoter (48). hRSV infection of epithelial cells in vitro induces the…”
BackgroundWest, K. H., Petrie, L., Haines, D. M., Konoby, C., Clark, E. G., Martin, K., & Ellis, J. A. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00265-5 · Cited by 72
Cook, P., Easton, A. J., & Eglin, R. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-10-2411 · Cited by 72
Self-citationTeng, M. N., & Collins, P. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6164-6171.2002 · Cited by 72 · cited 1×
“equately in its stead; a subsequent study (345) demonstrated”
BackgroundTsutsumi, H., Takeuchi, R., Ohsaki, M., Seki, K., & Chiba, S. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.1.99 · Cited by 70
Ruiz-Argüello, M. B., González-Reyes, L., Calder, L. J., Palomo, C., Martin, D. L., Saíz, M. J., García‐Barreno, B., Skehel, J. J., & Melero, J. A. (2002) · Virology · doi:10.1006/viro.2002.1497 · Cited by 70 · cited 1×
“remain associated with the F-protein subunits (19) and a novel”
BackgroundEpithelial Regulation of Innate Immunity to Respiratory Syncytial Virus
Garofalo, R. P., & Haeberle, H. A. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.5.f204 · Cited by 69 · cited 1×
“The biochemical responses of epithelial cell cultures infected with hRSV have been reviewed recently (78, 92, 131); this will permit us to”
BackgroundRandhawa, J. S., Marriott, A. C., Pringle, C. R., & Easton, A. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9849-9854.1997 · Cited by 69 · cited 2×
“The PVM transcriptional start signals are more variable than those of RSV or APV, which are absolutely conserved with the exception of the L gene (49, 296, 332).”
BackgroundSelf-citationBarr, J. N., Chambers, P., Pringle, C. R., & Easton, A. J. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-3-677 · Cited by 69 · cited 1×
“acid identity (60%) to the N protein of PVM (13) and has re-”
BackgroundSelf-citationDomachowske, J. B., Bonville, C. A., Easton, A. J., & Rosenberg, H. F. (2002) · The Journal of Infectious Diseases · doi:10.1086/341082 · Cited by 68 · cited 1×
“The gene array study of the transcriptional responses in wholemouse lung mRNA to infection with the pathogenic PVM strain J3666 likewise demonstrates increased expression of a specific array of proinflammatory mediators, including transcripts encoding murine MCP-1, RANTES, MCP-3, beta interferon, and 10 characterized…”
BackgroundSelf-citationFiedler, M. A., Wernke-Dollries, K., & Stark, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.9079-9082.1996 · Cited by 68
Jamaluddin, M., Garofalo, R., Ogra, P. L., & Brasier, A. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1554-1563.1996 · Cited by 66 · cited 1×
“(185, 254), ERK-2 (53), and unique hRSV-responding enhancer elements in the IL-8 gene promoter (48).”
BackgroundBukreyev, A. A., Whitehead, S. S., Bukreyeva, N., Murphy, B. R., & Collins, P. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2367 · Cited by 65 · cited 1×
“Interestingly, hRSV is sensitive to inhibition by gamma interferon (11, 20, 39, 99, 276, 365), and potential hRSV-mediated modulation pathways have been”
BackgroundGershwin, L. J., Gunther, R. A., Anderson, M. L., Woolums, A. R., McArthur-Vaughan, K., Randel, K. E., Boyle, G. A., Friebertshauser, K. E., & McInturff, P. S. (2000) · American Journal of Veterinary Research · doi:10.2460/ajvr.2000.61.291 · Cited by 64 · cited 1×
“feron in cells drained from pulmonary lymph (139, 214) and in peripheral blood mononuclear cells (257), detection of tumor”
BackgroundRespiratory Syncytial Virus Infection of Alveolar Macrophages in Adult Transplant Patients
Panuska, J. R., Hertz, M. I., Taraf, H., Villani, A., & Cirino, N. M. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.4_pt_1.934 · Cited by 63 · cited 1×
“The primary targets of hRSV in vivo are respiratory epithelial cells, although infection of alveolar macrophages has been reported (278).”
BackgroundGroothuis, J. R., & Nishida, H. (2002) · Pediatrics International · doi:10.1046/j.1442-200x.2002.01558.x · Cited by 62
Cited by
Inhibition of respiratory viruses by nasally administered siRNA
Bitko, V., Musiyenko, A., Shulyayeva, O., & Barik, S. (2005) · Nature Medicine · doi:10.1038/nm1164 · Cited by 725
Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection
Openshaw, P. J. M., & Tregoning, J. S. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.541-555.2005 · Cited by 292
Metadata
- Authors
- Easton, A. J., Domachowske, J. B., & Rosenberg, H. F.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2004-04
- Volume
- 17
- Issue
- 2
- Pages
- 390-412
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2135270248
- Cited by
- 212
- References
- 267
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.